Literature DB >> 17641855

Expression of Th17 cytokines in skin lesions of patients with psoriasis.

Jiawen Li1, Xu'e Chen, Zhixiang Liu, Qing Yue, Houjun Liu.   

Abstract

In order to investigate the role of Th17 cytokines in the pathogenesis of psoriasis, reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the expression of IL-17, IL-23 (p19/p40), and IL-6 in skin lesions and non-lesions of the patients with psoriasis and skin tissues of normal subjects. The results showed that the mRNA expression levels of IL-17, IL-23p19, IL-23p40 and IL-6 in psoriasis lesion were significantly higher than those of non-lesions (1.231 +/- 0.843 vs 1.003 +/- 0.044, 1.166 +/- 0.142 vs 0.765 +/- 0.133, 1.125 +/- 0.104 vs 0.730 +/- 0.103, 1.186 +/- 0.222 vs 0.976 +/- 0.122, respectively, all P < 0.05). Meanwhile, The expression levels of IL-17 mRNA, IL-23p19 mRNA, IL-23p40 mRNA and IL-6 mRNA were higher in non-lesions than those in normal skin tissues (1.003 +/- 0.044 vs 0.620 +/- 0.104, 0.765 +/- 0.133 vs 0.584 +/- 0.078, 0.730 +/- 0.103 vs 0.000 +/- 0.000, 0.976 +/- 0.122 vs 0.656 +/- 0.121, respectively, all P < 0.05). The overexpression of Th17 cytokines in the skin lesions of patients with psoriasis may indicate that Th17 cytokines play a very important role in the immunopathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641855     DOI: 10.1007/s11596-007-0329-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  T(H)-17: a giant step from T(H)1 and T(H)2.

Authors:  Thomas A Wynn
Journal:  Nat Immunol       Date:  2005-11       Impact factor: 25.606

Review 2.  Expanding the effector CD4 T-cell repertoire: the Th17 lineage.

Authors:  Laurie E Harrington; Paul R Mangan; Casey T Weaver
Journal:  Curr Opin Immunol       Date:  2006-04-17       Impact factor: 7.486

3.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

5.  Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.

Authors:  Yi Chen; Claire L Langrish; Brent McKenzie; Barbara Joyce-Shaikh; Jason S Stumhofer; Terrill McClanahan; Wendy Blumenschein; Tatyana Churakovsa; Justin Low; Leonard Presta; Christopher A Hunter; Robert A Kastelein; Daniel J Cua
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

6.  Microbial lipopeptides induce the production of IL-17 in Th cells.

Authors:  C Infante-Duarte; H F Horton; M C Byrne; T Kamradt
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

Review 7.  Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells.

Authors:  Chen Dong
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

8.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

  8 in total
  28 in total

Review 1.  Application of angiogenesis to clinical dermatology.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Adv Dermatol       Date:  2008

2.  Elevated serum levels of interleukin-17A in uveitis patients.

Authors:  Shayma Jawad; Baoying Liu; Elvira Agron; Robert B Nussenblatt; H Nida Sen
Journal:  Ocul Immunol Inflamm       Date:  2013-08-19       Impact factor: 3.070

3.  Interleukin-17A Plays the Same Role on Mice Acute Lung Injury Respectively Induced by Lipopolysaccharide and Paraquat.

Authors:  Hong-Wei Song; Chen Yang; Wei Liu; Xiao-Wei Liu; Zhi Liu; Feng Gao
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

4.  Expression of IRF-4 and IBP in skin lesions of patients with psoriasis vulgaris.

Authors:  Anhong Ni; Hongxiang Chen; Yan Wu; Wen Li; Shanjuan Chen; Jiawen Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

5.  Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis.

Authors:  Meaghan E Killeen; Laura Ferris; Erine A Kupetsky; Louis Falo; Alicia R Mathers
Journal:  J Immunol       Date:  2013-03-11       Impact factor: 5.422

6.  Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial.

Authors:  M Caproni; E Antiga; L Melani; W Volpi; E Del Bianco; P Fabbri
Journal:  J Clin Immunol       Date:  2008-09-02       Impact factor: 8.317

7.  Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

Authors:  K E Nograles; L C Zaba; E Guttman-Yassky; J Fuentes-Duculan; M Suárez-Fariñas; I Cardinale; A Khatcherian; J Gonzalez; K C Pierson; T R White; C Pensabene; I Coats; I Novitskaya; M A Lowes; J G Krueger
Journal:  Br J Dermatol       Date:  2008-08-05       Impact factor: 9.302

8.  IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.

Authors:  Kristine E Nograles; Lisa C Zaba; Avner Shemer; Judilyn Fuentes-Duculan; Irma Cardinale; Toyoko Kikuchi; Michal Ramon; Reuven Bergman; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2009-05-12       Impact factor: 10.793

9.  Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells.

Authors:  Amanda M Nelson; Wei Zhao; Kathryn L Gilliland; Andrea L Zaenglein; Wenlei Liu; Diane M Thiboutot
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 10.  Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.

Authors:  Jillian Frieder; Dario Kivelevitch; Alan Menter
Journal:  Ther Adv Chronic Dis       Date:  2017-11-16       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.